NCT01774591View on ClinicalTrials.gov

Effect of Azilsartan on Aldosterone in Postmenopausal Females

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

January 31, 2016

Conditions
Hypertension
Interventions
DRUG

Azilsartan medoximil

All subjects were randomized to 80mg azilsartan medoxomil (azilsartan) daily or placebo and followed for six months.

DRUG

Placebo

All subjects were randomized to 80mg azilsartan medoxomil (azilsartan) daily or placebo and followed for six months.

Trial Locations (1)

60637

University of Chicago, Chicago

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

University of Chicago

OTHER